Plain-English translation of NCT06938100 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study looking at CADASIL, a genetic condition that affects blood vessels in the brain. Researchers want to collect information from patients with CADASIL—including your medical history, genetic test results, brain scans, and blood work—to understand how the disease develops differently in different people and to find new ways to treat it.
CADASIL affects people in different ways, and doctors don't yet fully understand why some people get sicker faster than others. By studying a large group of patients together, researchers hope to discover patterns that could help predict how the disease will progress in individual patients and identify personalized treatment options.
You likely qualify if…
You likely don't qualify if…
You would allow researchers to review your medical records, genetic test results, and previous brain imaging scans. You may also be asked to donate a blood sample or undergo additional testing. Some information may be collected once, while researchers may follow up with you over time to track how your condition evolves. The study does not involve taking a new medication or undergoing invasive procedures.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy
Spain
Enrollment target
~100 participants
Started
November 2023
Primary completion
April 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Anna Bersano, MD
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.